Biogen said Thursday it will pull its multiple sclerosis drug Zinbryta in Australia, nearly two weeks after the biotech company issued a worldwide withdrawal of […]
As Shine Lawyers awaits judgment in a marathon class action against Johnson & Johnson over its pelvic mesh implants, a separate class action by the […]
The lead plaintiffs in the class action against Johnson & Johnson over defective pelvic mesh implants said Wednesday they want to expand the size of […]
GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo […]
Reckitt Benckiser has filed an appeal against GlaxoSmithKline, after a judge found the consumer goods giant misled consumers with claims that Nurofen was a more […]
Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca’s cholesterol drug Crestor, two-and-a-half years after the […]
Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline’s legal bill after a judge found the drug giant misled consumers with claims that Nurofen […]
IP Australia handed a win Thursday to a company challenging a Bayer animal drug patent, but gave Bayer two months to address the patent application’s […]
The Australian Patent Office has shot down a patent application covering throat lozenges by consumer goods giant Reckitt-Benckiser on a challenge by rival Sanofi-Aventis. Citing […]
After a marathon six-month hearing over 89 days, closing submissions in the landmark vaginal mesh class action against Johnson & Johnson in the Federal Court […]